Clinical Trials Browser

Interventional × ARQ 197 × Head & Neck × Clear all

NCT01696955 2018-12-19

Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed by Surgery

Phase 2 Completed

81 enrolled 14 charts

Squamous Cell Carcinoma of Head and Neck